Account
Publications
25.10.2023
ISPOR Europe 2023: Can Just Three PICOs be Feasibl...

This research aims to understand if just three PICOs are feasible by analysing recent HTA assessment...

Read more
Publications
25.10.2023
ISPOR Europe 2023: How Aware Are Biotech and Pharm...

Our research aims to gauge awareness of the new EU HTA process within the pharmaceutical industry in...

Read more
Publications
25.10.2023
ISPOR Europe 2023: Evaluation and Reimbursement of...

Our study compares and contrasts the evaluation and reimbursement pathways for digital therapeutics ...

Read more
Publications
25.10.2023
ISPOR Europe 2023: How Has NICE’s Severity M...

Our study aims to understand how the severity modifier has been implemented so far and its impact on...

Read more
Articles
11.10.2023
Unlocking the Potential of Cell and Gene Therapy: ...

We outline the challenges pharma companies encounter when launching cell and gene therapies, and ass...

Read more
Insider Insights
06.10.2023
Germany’s Health Ministry Shifts Focus to Di...

Germany is reshaping its Ministry of Health to prioritize the prevention of diseases like cancer, de...

Read more
Insider Insights
02.10.2023
AIFA Reform: CPR and CTS committees extended again

Discover the latest developments in AIFA reform as delays persist with the extension of CTS and CPR ...

Read more
Insider Insights
21.09.2023
France's €1B 2024 Reimbursement Savings Goal

French government's ambitious plan to save €1 billion in healthcare expenses by 2024 through new r...

Read more
Insider Insights
14.09.2023
AMR Subscription Model Consultation by NHS England

Learn about the ground breaking consultation by NHS England and NICE on expanding the Antimicrobial ...

Read more
Insider Insights
12.09.2023
New Additions to HTA International Collaboration

In a ground breaking move, the international collaboration among six prominent health technology ass...

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.